Copyright © 2012 Vinicius Preti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. P. H. Sugarbaker, “New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?” Lancet Oncology, vol. 7, no. 1, pp. 69–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
2. T. D. Yan, L. Welch, D. Black, and P. H. Sugarbaker, “A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma,” Annals of Oncology, vol. 18, no. 5, pp. 827–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
3. T. C. Chua, W. Liauw, and D. L. Morris, “Colorectal cancer: prevention and treatment of peritoneal metastases,” in Cytoreductive Surgery and Perioperative Chemotherapy For Peritoneal Surface Malignancy: Textbook and Video Atlas, P. H. Sugarbaker, Ed., Cine-Med, Woodbury, Conn, USA, 2012.
4. O. Glehen, Y. Yonemura, and P. H. Sugarbaker, “Prevention and treatment of peritoneal metastases from gastric cancer,” in Cytoreductive Surgery and Perioperative Chemotherapy For Peritoneal Surface Malignancy: Textbook and Video Atlas, P. H. Sugarbaker, Ed., Cine-Med, Woodbury, Conn, USA, 2012.
5. C. W. Helm, “Epithelial ovarian cancer with peritoneal metastases,” in Cytoreductive Surgery and Perioperative Chemotherapy For Peritoneal Surface Malignancy: Textbook and Video Atlas, P. H. Sugarbaker, Ed., Cine-Med, Woodbury, Conn, USA, 2012.
6. R. M. Smeenk, V. J. Verwaal, and F. A. N. Zoetmulder, “Learning curve of combined modality treatment in peritoneal surface disease,” British Journal of Surgery, vol. 94, no. 11, pp. 1408–1414, 2007. View at Publisher · View at Google Scholar · View at Scopus
7. F. Mohamed and B. J. Moran, “Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve,” Cancer Journal, vol. 15, no. 3, pp. 196–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
8. S. A. Ahmad, J. Kim, J. J. Sussman et al., “Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion,” Annals of Surgical Oncology, vol. 11, no. 4, pp. 387–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
9. V. A. Lawrence, S. G. Hilsenbeck, C. D. Mulrow, R. Dhanda, J. Sapp, and C. P. Page, “Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery,” Journal of General Internal Medicine, vol. 10, no. 12, pp. 671–678, 1995. View at Scopus
10. P. H. Sugarbaker, “Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach,” Expert Opinion on Pharmacotherapy, vol. 10, no. 12, pp. 1965–1977, 2009. View at Publisher · View at Google Scholar · View at Scopus
11. P. Jacquet and P. H. Sugarbaker, “Current methodologies for clinical assessment of patients with peritoneal carcinomatosis,” Journal of Experimental and Clinical Cancer Research, vol. 15, no. 1, pp. 49–58, 1996. View at Scopus
12. P. H. Sugarbaker, K. Van der Speeten, O. A. Stuart, D. Chang, and H. Mahteme, “Patient- and treatment-related variables, adverse events and their statistical relationship for treatment of peritoneal metastases,” in Cytoreductive Surgery and Perioperative Chemotherapy For Peritoneal Surface Malignancy: Textbook and Video Atlas, P. H. Sugarbaker, Ed.
13. T. D. Yan, L. Zappa, G. Edwards, R. Alderman, C. E. Marquardt, and P. H. Sugarbaker, “Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-Appendiceal peritoneal carcinomatosis from a prospective database,” Journal of Surgical Oncology, vol. 96, no. 2, pp. 102–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
14. S. Kusamura, R. Younan, D. Baratti et al., “Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique,” Cancer, vol. 106, no. 5, pp. 1144–1153, 2006. View at Publisher · View at Google Scholar · View at Scopus
15. E. Chéreau, M. Ballester, F. Selle et al., “Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer,” An International Journal of Obstetrics and Gynaecology, vol. 116, no. 8, pp. 1062–1068, 2009. View at Publisher · View at Google Scholar · View at Scopus
16. S. C. Dowdy, R. T. Loewen, G. Aletti, S. S. Feitoza, and W. Cliby, “Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma,” Gynecologic Oncology, vol. 109, no. 2, pp. 303–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
17. A. D. Stephens, R. Alderman, D. Chang et al., “Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique,” Annals of Surgical Oncology, vol. 6, no. 8, pp. 790–796, 1999. View at Scopus
18. A. Capone, M. Valle, F. Proietti, O. Federici, A. Garofalo, and N. Petrosillo, “Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis,” Journal of Surgical Oncology, vol. 96, no. 6, pp. 507–513, 2007. View at Publisher · View at Google Scholar · View at Scopus
19. O. Glehen, D. Osinsky, E. Cotte et al., “Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures,” Annals of Surgical Oncology, vol. 10, no. 8, pp. 863–869, 2003. View at Publisher · View at Google Scholar · View at Scopus
20. U. Schmidt, M. H. Dahlke, J. Klempnauer, H. J. Schlitt, and P. Piso, “Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy,” European Journal of Surgical Oncology, vol. 31, no. 1, pp. 53–58, 2005. View at Publisher · View at Google Scholar · View at Scopus
21. H. Müller, M. Hahn, L. Weller, and J. Simsa, “Strategies to reduce perioperative morbidity in cytoreductive surgery,” Hepato-Gastroenterology, vol. 55, no. 86-87, pp. 1523–1529, 2008. View at Scopus